No Data
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
US Manufacturing Index Rises To 43, Highest Since 2020
Express News | COLLEGIUM PHARMACEUTICAL Announced That Health Canada Has Approved Its Drug Jornay-PM For The Treatment Of ADHD In Children
Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly
Collegium to Participate in Upcoming Investor Conferences
Jefferies Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $40
Can Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Improve Its Returns?No Data
No Data
